Pricing Log in Create free account

Avenue Therapeutics, Inc. (ATXI) vs Virpax Pharmaceuticals, Inc. (VRPX)

Avenue Therapeutics, Inc. and Virpax Pharmaceuticals, Inc. are both Biotechnology companies. Avenue Therapeutics, Inc. is the larger, with a market value of $680.0K against $160.0K — 4.2× the size. Across the 8 metrics below, Avenue Therapeutics, Inc. leads on 4 and Virpax Pharmaceuticals, Inc. on 4.

Valuation

Metric ATXI VRPX Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 2.49 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.05 0.04 0.64
EV/Sales n/m n/m 9.21
Earnings yield (197.67%) 0.00% (33.15%)
Free cash flow yield (97.68%) 0.00% (25.50%)

Profitability

Metric ATXI VRPX Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.30%) (2,364.98%) (56.36%)
Return on assets (90.50%) (215.80%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATXI VRPX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 89.70% 78.10% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATXI VRPX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.40 0.63 4.72
Net debt to EBITDA 0.93 0.13 0.96

Dividend

Metric ATXI VRPX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ATXI VRPX Biotechnology median
Market cap 680.00k 160.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack